Noticias sobre VIH/SIDA
Dissent on doxyPEP: recent guidelines becoming more cautious
Two recent statements about taking the antibiotic doxycycline up to 72 hours after sex to prevent bacterial sexually transmitted infections, a prevention intervention known as doxyPEP, are notably more cautious about recommending its use than the first guidelines from California.
Categorías: VIH/SIDA
Relationship skills can reduce the risk of HIV in young male couples
An online HIV prevention and relationship education programme developed by Dr Michael Newcomb and colleagues from Northwestern University is proving effective in reducing the risk of HIV in young male couples in the United States, a group disproportionately affected by HIV.
Categorías: VIH/SIDA
Switching from TAF to TDF leads to weight loss
Switching from tenofovir alafenamide (TAF) to the older formulation of tenofovir disoproxil (TDF) resulted in modest weight loss in people with HIV in the Swiss HIV Cohort, researchers report in the journal Clinical Infectious Diseases.
Switching from TAF to TDF also brought benefits in the forms of reduced cholesterol and triglycerides.
In contrast, switching from TAF-containing treatment to a two-drug combination of dolutegravir/lamivudine or injectable cabotegravir/rilpivirine did not lead to any changes in weight.
Categorías: VIH/SIDA
ONUSIDA celebra la sentencia del Tribunal que protege los derechos de las personas LGBTQ en Dominica
ONUSIDA celebra la decisión del Tribunal Superior de Dominica de proteger los derechos de las personas LGBTQ en Dominica.
Categorías: VIH/SIDA
Danish study finds that STI rates in gay men increase before they start PrEP, not after
A Danish study which was able to chart the annual incidence of the three bacterial STIs, chlamydia, gonorrhoea and syphilis, in people attending sexual health clinics both before and after they started PrEP has found that they had more than twice as many (115% more) STI diagnoses while on PrEP than they had some time before starting it.
Categorías: VIH/SIDA
Cryptococcal meningitis persists in Botswana, despite high antiretroviral coverage
A study of cryptococcal meningitis incidence in people with HIV in Botswana shows that incidence has halved since 2015 and that the decline is correlated to increased antiretroviral coverage. But the study found that men were more likely to be diagnosed with cryptococcal meningitis than women and that illness related to advanced HIV remains a substantial problem despite achieving near-universal treatment coverage.
Categorías: VIH/SIDA
More evidence that PrEP works as well for women
In a presentation at last month’s Conference on Retroviruses and Opportunistic Infections (CROI 2024), the case was made that event-driven pre-exposure prophylaxis (PrEP) might work just as well for women as men, and should be offered to them as an option.
Categorías: VIH/SIDA
ONUSIDA pide que se mantengan y amplíen las inversiones en salud y VIH en las reuniones de primavera del FMI y el Banco Mundial
Urge reestructurar la deuda y reformar el sistema fiscal mundial para financiar los sistemas sanitarios y otros servicios esenciales
Categorías: VIH/SIDA
Adolescent mothers with HIV in South Africa have poorer HIV outcomes than non-mothers, study finds
Adolescent girls who are mothers and living with HIV, experience more interruptions in their antiretroviral (ART) treatment, have poorer adherence, poorer clinical attendance and lower viral suppression rates compared to those who are not mothers, a recent study published in the Journal of the International AIDS Society found.
Categorías: VIH/SIDA
Un nuevo informe insta a ampliar los servicios relacionados con el VIH para mejorar la salud en general
Un nuevo informe publicado hoy por ONUSIDA y Amigos de la Lucha Mundial contra el Sida, la Tuberculosis y la Malaria muestra cómo los países están aprovechando sus respuestas al VIH tanto para asegurar el impacto en la respuesta al VIH como para mejorar la salud y el bienestar nacional en general. El informe concluye que invertir ahora para acabar con el sida como amenaza para la salud pública de aquí a 2030 no solo permitirá cumplir el compromiso de acabar con la pandemia, sino que también aumentará los beneficios sanitarios más amplios de las inversiones específicas en el VIH.
Categorías: VIH/SIDA
Growing racial and gender PrEP inequities in England, despite increased access
The proportion of Black African women diagnosed with HIV increased between 2017 and 2021 in England, while the proportion of new diagnoses among White men dropped by 20%. Over this period, the proportion of PrEP users who were women, including Black African women, fell. Thus, when comparing Black African women to White men, and women to men, PrEP inequities have increased substantially, despite wider PrEP accessibility.
Categorías: VIH/SIDA
Zimbabwe: low-cost, brief psychological intervention helps people with HIV stay virally suppressed
Results from a study published in PLOS Global Public Health show that people with HIV and common mental disorders in Zimbabwe can benefit from a low-cost and brief psychological intervention called the Friendship Bench to improve their mental health outcomes and, consequently, sustain viral suppression on antiretroviral therapy.
Categorías: VIH/SIDA
To breastfeed or not: mothers living with HIV in African countries still unclear on what to do
New mothers living with HIV are often unsure about whether or not to breastfeed their children, and for how long, the African Workshop on HIV & Women held in Nairobi, Kenya in February heard. This is because their infant feeding practices are influenced by the people around them, which makes the decision-making process even more difficult.
Categorías: VIH/SIDA
HIV clinicians in Spain underestimate their patients’ HIV-related symptoms
Despite advances in HIV care and treatment, a study has found a large proportion of people with HIV still experience symptoms that are underestimated or unacknowledged by their HIV doctors. Dr José Galindo Puerto of the Spanish AIDS Interdisciplinary Society (SEISIDA) and colleagues found discrepancies between the frequency and burdens of HIV and HIV treatment symptoms reported by Spaniards living with HIV and the HIV specialists caring for them. Their results highlight a need for better communication between clinicians and patients.
Categorías: VIH/SIDA
Adolescents prefer long-acting injectables to daily oral HIV treatment, study finds
How young people feel about long-acting injectable treatment remains largely unexplored. The More Options for Children and Adolescents (MOCHA) study provides some insight into the experiences of young people aged 12-18 who have switched to long-acting cabotegravir / rilpivirine based treatment. It is the first to examine use of long-acting injectable antiretrovirals in virally suppressed adolescents.
Categorías: VIH/SIDA
Big falls in HIV deaths in high-income countries – except for injecting drug users
While there have been reductions in the rates of most major causes of death among people with HIV in North America and Europe since 1996, people who inject drugs – particularly women – remain vulnerable to early death.
Background
Before 1996 – when combination antiretroviral therapy (ART) became the mainstay of HIV treatment – death from AIDS was a near inevitability, even in high-income countries. Due to ART’s high effectiveness at suppressing HIV, AIDS-related deaths have declined steeply, particularly in Europe and North America.
[GLOSSARY]
Categorías: VIH/SIDA
Nigerian analysis defines what makes a youth-friendly HIV service work
A recent study identifies the factors which contribute to the effective delivery of youth-friendly services, so as to achieve better outcomes for adolescents.
Globally, around five million adolescents (aged 15-24) are living with HIV. There is consensus that youth-friendly approaches to delivering care do support better health outcomes. However, there are gaps in knowledge about how they work in practice. This analysis explored whether specific mechanisms could influence outcomes.
Categorías: VIH/SIDA
Why is the roll-out of injectable PrEP taking so long?
A symposium at the Conference on Retroviruses and Opportunistic Infections (CROI 2024) earlier this month included presentations advocating changes in practice on what might be called opposite ends of the menu of PrEP options now on offer.
Categorías: VIH/SIDA
Weight gain on HIV treatment: more than a 'return to health' phenomenon?
Weight gain on antiretroviral treatment is not solely a ‘return to health’ effect, research presented earlier this month at the Conference on Retroviruses and Opportunistic Infections (CROI 2024) suggests.
Categorías: VIH/SIDA
The US opioid crisis has reached older people with HIV
People with HIV aged 65 and older were more likely to be prescribed opioids and be diagnosed with opioid use disorder than HIV-negative older adults in the US, according to data presented by Dr Stephanie Shiau to the Conference on Retroviruses and Opportunistic Infections (CROI 2024) in Denver recently.
Categorías: VIH/SIDA